• 11943 Citations
  • 55 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Esteban Celis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Treatment of Melanoma with Optimzed Peptide Vaccines

Celis, E.

6/1/094/30/16

Project: Research project

Optimization of Peptide Based Vaccines for Cancer

Celis, E.

9/1/048/31/10

Project: Research project

SPORE in Prostate Cancer

Young, C., Fatemi, M., Morris, J. C., Thibodeau, S. N., Vile, R., Vasmatzis, G., Jenkins, R. B., Bergstralh, E. J., Cheville, J., Klee, G., Tindall, D. J., Davis, B., Sargent, D., Layton, D., Vuk-Pavlovic, S., Celis, E., Thibodeau, S. N., Vile, R., Vasmatzis, G., Young, C., Cheville, J., Davis, B., TINDALL, D., Jenkins, R. & Morris, J.

8/31/018/31/13

Project: Research project

IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER

Celis, E.

7/20/996/30/02

Project: Research project

Research Output

Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw

Elsayed, R., Kurago, Z., Cutler, C. W., Arce, R. M., Gerber, J., Celis, E., Sultan, H., Elashiry, M., Meghil, M., Sun, C., Auersvald, C. M., Awad, M. E., Zeitoun, R., Elsayed, R., Eldin M. Elshikh, M., Isales, C. & Elsalanty, M. E., Feb 1 2020, In : FASEB Journal. 34, 2, p. 2595-2608 14 p.

Research output: Contribution to journalArticle

Open Access
  • Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

    Piranlioglu, R., Lee, E. M., Ouzounova, M., Bollag, R. J., Vinyard, A., Arbab, A. S., Marasco, D., Guzel, M., Cowell, J. K., Thangaraju, M., Chadli, A., Hassan, K. A., Wicha, M. S., Celis, E. & Korkaya, H., Dec 1 2019, In : Nature communications. 10, 1, 1430.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

    Sultan, H., Kumai, T., Nagato, T., Wu, J., Salazar, A. M. & Celis, E., Mar 13 2019, In : Cancer Immunology, Immunotherapy. 68, 3, p. 455-466 12 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

    Klement, J. D., Paschall, A. V., Redd, P. S., Ibrahim, M. L., Lu, C., Yang, D., Celis, E., Abrams, S. I., Ozato, K. & Liu, K., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5549-5560 12 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations

    H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells

    Redd, P. S., Lu, C., Klement, J. D., Ibrahim, M. L., Zhou, G., Kumai, T., Celis, E. & Liu, K., Sep 2 2018, In : OncoImmunology. 7, 9, e1483302.

    Research output: Contribution to journalArticle

  • 5 Scopus citations